Magnus Ronn
Keine laufenden Positionen mehr
Profil
Dr. Magnus Ronn is Senior VP-Chemistry, Manufacturing & Control at Tetraphase Pharmaceuticals, Inc.
Dr. Ronn was previously employed as Senior Scientist by Millennium Pharmaceuticals, Inc. and Scientist by Roche Colorado Corp.
He received his undergraduate degree from the University of Uppsala, an undergraduate degree from The University of Colorado, and a doctorate degree from the University of Uppsala.
Ehemalige bekannte Positionen von Magnus Ronn
| Unternehmen | Position | Ende |
|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 |
Roche Colorado Corp.
 Roche Colorado Corp. Medical SpecialtiesHealth Technology Roche Colorado Corp. manufactures peptides for commercial pharmaceutical use. It also manufactures drugs such as the anti-HIV treatments Fuzeon, Invirase, and the influenza drug Tamiflu. It also provides contract manufacturing of peptides and a protein-like compound used in pharmaceuticals. The company was founded in 1967 and is headquartered in Boulder, CO. | Technik-/Wissenschafts-/F&E-Leiter | - |
| TETRAPHASE PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Magnus Ronn
| University of Uppsala | Doctorate Degree |
| The University of Colorado | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Roche Colorado Corp.
Roche Colorado Corp. Medical SpecialtiesHealth Technology Roche Colorado Corp. manufactures peptides for commercial pharmaceutical use. It also manufactures drugs such as the anti-HIV treatments Fuzeon, Invirase, and the influenza drug Tamiflu. It also provides contract manufacturing of peptides and a protein-like compound used in pharmaceuticals. The company was founded in 1967 and is headquartered in Boulder, CO. | Health Technology |
